Weekly Reports | Sep 14 2012
Our top ten news from 07 September 2012 to 14 September 2012 (ranked according to popularity).
Monday 10 September 2012 – 10:00 AM
Weekly update on recommendation, target price, and earnings forecast changes.
NRW Holdings has clarified its loss of contract work due to Fortescue's expansion deferral, but brokers agree the impact is minimal.
Jonathan Barratt of Barratt's Bulletin discusses the normalising of the iron ore industry and its impact on the Australian economy.
The uranium spot market was quiet again last week, although buyers and sellers seem to be closing their price expectation gap.
By Rudi Filapek-Vandyck, Editor FNArena It is not an item that receives regular attention here at FNAre
Tuesday 11 September 2012 – 02:21 PM
A glance through the latest expert views and predictions about commodities with revisions to oil price forecasts, the risk Australian LNG plays miss their market window and a review of mining contractors.
Falling iron ore prices and shelved capex plans have the market running scared, but analysts ensure Australia's mining boom is far from over.
Bell Potter quite likes Neuren Pharmaceuticals because of progress with drugs for Traumatic Brain Injury and Autism Spectrum Disorders, plus developments in a Parkinson's Disease compound offer.
Last week saw brokers remain focused on macro issues impacting the Banking and Retail sectors and the equities outlook post reporting season adjustments.
The FNArena Editor explained on Switzer TV the share market has become a risky proposition for investors, but not all risks are the same.